Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults
- 1 October 2017
- Vol. 35 (42) , 5708-5713
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences
- National Institutes of Health (R01GM111121)
This publication has 24 references indexed in Scilit:
- Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on EstimatesClinical Infectious Diseases, 2013
- Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysisBMC Medicine, 2013
- Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort studyThorax, 2013
- Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccineVaccine, 2012
- Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trialVaccine, 2011
- Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United StatesVaccine, 2008
- The annual impact of seasonal influenza in the US: Measuring disease burden and costsVaccine, 2007
- Clinical Effectiveness of Influenza Vaccination in Persons Younger Than 65 Years With High-Risk Medical ConditionsArchives of internal medicine (1960), 2005
- Toward Consistency in Cost-Utility AnalysesMedical Care, 1998
- Pneumonia and Influenza Deaths During EpidemicsArchives of internal medicine (1960), 1982